These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Elucidating the structural mechanisms for biological activity of the chemokine family. Baysal C; Atilgan AR Proteins; 2001 May; 43(2):150-60. PubMed ID: 11276085 [TBL] [Abstract][Full Text] [Related]
6. New therapeutics that modulate chemokine networks. Schwarz MK; Wells TN Nat Rev Drug Discov; 2002 May; 1(5):347-58. PubMed ID: 12120410 [TBL] [Abstract][Full Text] [Related]
7. Why chemokines are cytokines while their receptors are not cytokine ones? Goncharova LB; Tarakanov AO Curr Med Chem; 2008; 15(13):1297-304. PubMed ID: 18537609 [TBL] [Abstract][Full Text] [Related]
9. Recent advances in chemokines and chemokine receptors. Zlotnik A; Morales J; Hedrick JA Crit Rev Immunol; 1999; 19(1):1-47. PubMed ID: 9987599 [TBL] [Abstract][Full Text] [Related]
10. Chemokines: roles in leukocyte development, trafficking, and effector function. Ono SJ; Nakamura T; Miyazaki D; Ohbayashi M; Dawson M; Toda M J Allergy Clin Immunol; 2003 Jun; 111(6):1185-99; quiz 1200. PubMed ID: 12789214 [TBL] [Abstract][Full Text] [Related]
11. A burgeoning family of biological mediators: chemokines and chemokine receptors. Le Y; Gong W; Shen W; Li B; Dunlop NM; Wang JM Arch Immunol Ther Exp (Warsz); 2000; 48(3):143-50. PubMed ID: 10912618 [TBL] [Abstract][Full Text] [Related]
12. [Chemokines--perspectives for using agents that block their action in therapy]. Waśniowska K Postepy Hig Med Dosw (Online); 2004 Mar; 58():37-46. PubMed ID: 15069373 [TBL] [Abstract][Full Text] [Related]
13. Identification of oligopeptide sequences which inhibit migration induced by a wide range of chemokines. Reckless J; Grainger DJ Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):803-11. PubMed ID: 10359667 [TBL] [Abstract][Full Text] [Related]
14. Chemokine-receptor interactions: GPCRs, glycosaminoglycans and viral chemokine binding proteins. Lau EK; Allen S; Hsu AR; Handel TM Adv Protein Chem; 2004; 68():351-91. PubMed ID: 15500866 [TBL] [Abstract][Full Text] [Related]
15. Chemokines and brain functions. Banisadr G; Rostène W; Kitabgi P; Parsadaniantz SM Curr Drug Targets Inflamm Allergy; 2005 Jun; 4(3):387-99. PubMed ID: 16101548 [TBL] [Abstract][Full Text] [Related]
16. Chapter 12. The use of receptor homology modeling to facilitate the design of selective chemokine receptor antagonists. Carter PH; Tebben AJ Methods Enzymol; 2009; 461():249-79. PubMed ID: 19480923 [TBL] [Abstract][Full Text] [Related]
17. Chemokines. Laing KJ; Secombes CJ Dev Comp Immunol; 2004 May; 28(5):443-60. PubMed ID: 15062643 [TBL] [Abstract][Full Text] [Related]
18. Function, diversity and therapeutic potential of the N-terminal domain of human chemokine receptors. Szpakowska M; Fievez V; Arumugan K; van Nuland N; Schmit JC; Chevigné A Biochem Pharmacol; 2012 Nov; 84(10):1366-80. PubMed ID: 22935450 [TBL] [Abstract][Full Text] [Related]
19. The chemokine family. Potential therapeutic targets from allergy to HIV infection. Proudfoot AE Eur J Dermatol; 1998; 8(3):147-57. PubMed ID: 9649701 [TBL] [Abstract][Full Text] [Related]
20. Conservation of unfavorable sequence motifs that contribute to the chemokine quaternary state. Kagiampakis I; Jin H; Kim S; Vannucci M; LiWang PJ; Tsai J Biochemistry; 2008 Oct; 47(40):10637-48. PubMed ID: 18781776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]